Get the app
US › Healthcare

Codexis Inc (CDXS)

US · Healthcare · Biotechnology

$1.24-8.82%
Last close · 2026-10-16

Latest quarter · ended 2026-06-30

Revenue
$14.9M
Revenue YoY
-2.7%
Net profit
$-12.0M
EPS
$-0.13
EPS estimate
$-0.17
Net margin
-80.5%

EPS came in at -0.13 against a street estimate of -0.17 — a beat of 23.5%.

Key statistics

Market cap
$141.3M
Forward P/E
149.3
P/B
4.63
Book value
$0.36
EPS (TTM)
$-0.32
52-week high
$2.98
52-week low
$0.96
50-day MA
$1.46
200-day MA
$1.84
Beta
2.55

Analyst view

Analysts rate Codexis Inc a buy (6 buy, 2 hold, 0 sell out of 8) with an average price target of $6.14.

Shareholding

Insiders
7.12%
Institutions
70.17%

Largest institutional holders

FundStake
BlackRock Inc6.66%
Nantahala Capital Management, LLC6.63%
Opaleye Management Inc6.20%
Aberdeen Group PLC6.19%
Millennium Management LLC5.07%
Telemark Asset Management, LLC3.52%
Ameriprise Financial Inc3.48%
Vanguard Capital Management, LLC3.31%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Codexis Inc — free to start.

Open in the appGoogle PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncAmgen IncGilead Sciences IncAbbott LaboratoriesNovo Nordisk A/S

Data updated 2026-10-19.